Correlation Between AN2 Therapeutics and Entera Bio
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Entera Bio, you can compare the effects of market volatilities on AN2 Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Entera Bio.
Diversification Opportunities for AN2 Therapeutics and Entera Bio
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and Entera is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Entera Bio go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Entera Bio
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 2.1 times more return on investment than Entera Bio. However, AN2 Therapeutics is 2.1 times more volatile than Entera Bio. It trades about 0.2 of its potential returns per unit of risk. Entera Bio is currently generating about -0.21 per unit of risk. If you would invest 107.00 in AN2 Therapeutics on August 25, 2024 and sell it today you would earn a total of 27.00 from holding AN2 Therapeutics or generate 25.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Entera Bio
Performance |
| Timeline |
| AN2 Therapeutics |
| Entera Bio |
AN2 Therapeutics and Entera Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Entera Bio
The main advantage of trading using opposite AN2 Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Vaccinex | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |